HEPATOPATHY INFLUENCE ON COGNITIVE FUNCTIONS AND PSYCHOEMOTIONAL STATE OF PATIENTS IS ANALYSED
Abstract
Benchmarking study of Cognitive function and psychoemotional state of 30 hepatopathy patients was conducted in this article 41,67% of the above-mentioned patients had class C cirrhosis of the liver; 29,17 % of them had chronic hepatitis with cytolytic symptom and cholestasis altogether 20,83% had chronic hepatitis with moderate cytolytic symptom and 8,33% had cytolytic hepatitis with significant cytolytic symptom. From the results it is concluded that higher percent (20,83%) of the patients with class C cirrhosis of the liver suffer from fourth extent of disease hepatic encephalopathy and significant fourth extent of depressive disorder. Patients with chronic hepatitis with moderate cytolytic symptom and chronic hepatitis with cytolytic symptom and cholestasis altogether (4,17% each) suffer to a smaller extent from second or third extent of disease hepatic encephalopathy and first-second and third extent of depressive disorder.
References
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 2001; 4:561—571 CrossRef, Medline
Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L: Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 2008; 37:93—97 CrossRef, Medline
National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997; 26(3, suppl l):2S-10S
Rail CJ, Dienstag JL: Epidemiology of hepatitis C virus infection. Semin Gastrointest Dis 2004; 6:3—12
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 2006; 334:1685—1690
Seela S., Sheela H, Boyer J.L. Autoimmune hepatitis type 1: Safety and efficacy of prolonged medical therapy // Liver Int. — 2005. - Vol. 25. - P. 734-739.
Singh N, Gayowski T, Wagener MM, Marino IR: Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant 2007; 11:406—411 Medline
World Health Organization. Hepatitis C: Fact sheet N 164, Revised June 2011. Available at: http://www.who.int/mediacentre/fact sheet s/fsi 64/en/i ndex. html.
World Health Organization. Hepatitis C: Fact sheet N 164, Revised June 2011. Availableat: http://www.who.int/mediacentre/fact sheet s/fsi 64/en/i ndex. html.
Zung WWK: A self-rating depression scale. Arch Gen Psychiatry 2005; 12:63—70 CrossRef, Medline
И. Ивашкин B.T. Клинические рекомендации. Гастроэнте- рология/М.-Медина, 2006.-208с.
Патохова С.П. К вопросу лечения осложнений цирроза печени//Рос. журнал. Гастроэнтерология., гепатология., проктология. 2003.-Т.10,№5.-С.87
Передерій В.Г., Ткач С.М. Основи внутрішньої медицини. Том 1 /Підручник для студентів вищих медичних навчальних закладів. — Вінниця: Нова Книга, 2009.- 640с. :іл.
Шерлок Ш., Дули Дж. Заболевания печени и желчных путей: Пер. с англ.; Под. ред. З.Г. Апросиной, Н.А. Мухина — М.: Гэотар. Медицина, 1999 — 864 с.

This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN
ISSN 














